Skip to main content
Premium Trial:

Request an Annual Quote

Myriad Genetics Develops New Database to Identify Genes in CNS Disorders

Premium

SALT LAKE CITY--Myriad Genetics, a genomics company here, has announced a collaboration with Valley Mental Health that will develop a new database bringing together Myriad's genealogical database with approximately 100,000 anonymous patient records from Valley. The database will be used to identify genes involved in such central nervous system disorders as depression, bipolar disorder, and dementia.

Myriad will receive worldwide exclusive rights to diagnostic and therapeutic applications of data generated by the collaboration. Peter Meldrum, Myriad's president and CEO, called the collaboration "an invaluable resource for ad vancing this CNS gene discovery program."

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.